SensiScreen® FFPE
SensiScreen® FFPE qPCR Assays enable sensitive detection of somatic mutations in solid cancer biopsies. Using PentaBase’s unique INA® technology, they offer high sensitivity and consistent protocols across all assays. Designed for open platforms, they are available in Ready-to-Use or Dispense Ready formats to suit different workflow needs.